Technology
Health
Pharmaceutical

Millendo Therapeutics

$6.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.16 (2.35%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MLND and other stocks, options, ETFs, and crypto commission-free!

About MLND

Millendo Therapeutics, Inc. Common Stock, also called Millendo Therapeutics, is a biopharmaceutical company. Read More The company is engaged in the development of novel treatments for endocrine diseases. Its products include livoletide and nevanimibe. The company was founded in April, 2011 and is headquartered in Ann Arbor, MI.

Employees
34
Headquarters
Ann Arbor, Michigan
Founded
2011
Market Cap
93.62M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
17.80K
High Today
$7.00
Low Today
$6.64
Open Price
$6.83
Volume
13.49K
52 Week High
$17.34
52 Week Low
$6.64

Collections

Technology
Health
Pharmaceutical
Therapy
Biopharmaceutical
US
North America
Female CEOs

MLND Earnings

-$0.94
-$0.83
-$0.73
-$0.62
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 20, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.